PubRank

C Braggion

Author PubWeight™ 12.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review. J Hosp Infect 2006 1.57
2 Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report. Clin Infect Dis 2000 1.36
3 Prevalence and correlates of vertebral fractures in adults with cystic fibrosis. Bone 2004 1.02
4 Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: a national overview. J Cyst Fibros 2011 0.92
5 Prevalence of urinary incontinence in women with cystic fibrosis. BJU Int 2001 0.85
6 Evidence of transmission of a Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus clone: a family affair. Clin Microbiol Infect 2013 0.84
7 Non-invasive proportional assist and pressure support ventilation in patients with cystic fibrosis and chronic respiratory failure. Thorax 2002 0.83
8 Determinants of maximal transdiaphragmatic pressure in adults with cystic fibrosis. Am J Respir Crit Care Med 1994 0.81
9 Transcutaneous blood gas analysis during sleep and exercise in cystic fibrosis. Pediatr Pulmonol 1990 0.81
10 [Italian Cystic Fibrosis Registry: 10 years of activity]. Epidemiol Prev 1999 0.80
11 Case report: cystic fibrosis, lung transplantation, and the novel H1N1 flu. Transplant Proc 2010 0.79
12 Early bronchopulmonary involvement in Crohn disease: a case report. BMC Gastroenterol 2001 0.77
13 The costs of treatment of early and chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Chemother 2009 0.77
14 Bone mineral density in cystic fibrosis patients under the age of 18 years. Minerva Pediatr 2008 0.77
15 Influence of antacid and formulation on effectiveness of pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child 1987 0.75
16 [Clinical trial of several preparation types of the pancreatic extract Pancrex V in the treatment of cystic fibrosis]. Minerva Pediatr 1985 0.75
17 Parenteral administration of tobramycin for pulmonary exacerbations in cystic fibrosis patients: toxicity, serum levels and efficacy. J Chemother 2009 0.75